BeStock  
Stocks › Biotechnology › DYN

Dyne Therapeutics DYN

US equityMarket cap rank #2457Biotechnology
$15.50 −$0.53 (-3.31%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $15.50 0.00%
Open$15.91
Prev close$16.03
Day range$15.41 – $16.48
Volume2.23M
Market cap$2.90B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$197.07M-73.0% YoY
Net profit-$193.55M-79.1% YoY
Diluted EPS-$1.06-39.5% YoY
Free cash flow-$179.50M-63.2% YoY
Operating cash flow-$177.49M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-89.5MDec '24$-115.4MMar '25$-110.9MJun '25$-108.0MSep '25$-112.0MDec '25$-120.9MMar '26$-178.6MJun '26$-193.6MSep '26

Diluted EPS by quarter

-0.88Dec '24-1.05Mar '25-0.97Jun '25-0.76Sep '25-0.76Dec '25-0.73Mar '26-1.08Jun '26-1.06Sep '26

Free cash flow by quarter

$-85.4MDec '24$-106.9MMar '25$-94.8MJun '25$-110.0MSep '25$-112.3MDec '25$-145.1MMar '26$-131.8MJun '26$-179.5MSep '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-74.6%
Return on assets-57.6%
Return on invested capital-63.3%
Current ratio12.99
Liabilities / assets24.6%
Cash & investments$1.13B
Total debt$213.32M
Net cash (debt)$921.06M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $197.07M $181.66M $125.28M $468.18M $116.13M
Selling and Admin Expenses $35.33M $29.49M $24.39M $69.85M $20.70M
-General & Admin Expense $35.33M $29.49M $24.39M $69.85M $20.70M
Research & Development $161.74M $152.17M $100.89M $398.33M $95.43M
Operating Profit -$197.07M -$181.66M -$125.28M -$468.18M -$116.13M
Net Non-Operating Interest Income (Expense) $3.82M $3.19M $4.56M $23.67M $4.46M
Non-Operating Interest Income $9.77M $7.79M $8.76M $29.86M $7.66M
Non-Operating Interest Expense $5.95M $4.60M $4.20M $6.19M $3.19M
Other Income (Expense) -$296,000.00 -$88,000.00 -$133,000.00 -$1.70M -$289,000.00
Other Non-Operating Income (Expenses) -$296,000.00 -$88,000.00 -$133,000.00 -$1.70M -$289,000.00
Pretax Profit -$193.55M -$178.56M -$120.85M -$446.21M -$111.96M
Net Profit -$193.55M -$178.56M -$120.85M -$446.21M -$111.96M
Profit from Continuing Operations -$193.55M -$178.56M -$120.85M -$446.21M -$111.96M
Net Income to Parent Company -$193.55M -$178.56M -$120.85M -$446.21M -$111.96M
Net Income to Common Stockholders -$193.55M -$178.56M -$120.85M -$446.21M -$111.96M
Basic EPS -$1.06 -$1.08 -$0.73 -$3.47 -$0.76
Diluted EPS -$1.06 -$1.08 -$0.73 -$3.47 -$0.76

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.23B $994.01M $1.08B $1.19B $1.19B
Total Current Assets $1.18B $937.89M $1.02B $1.13B $1.13B
Cash and Cash Equivalents & Short-Term Investments $1.13B $898.48M $972.16M $1.11B $1.11B
-Cash and Cash Equivalents $913.20M $676.11M $753.10M $893.37M $893.37M
-Short Term Investments $221.18M $222.36M $219.05M $217.19M $217.19M
Other Current Assets $41.64M $39.41M $48.87M $16.03M $16.03M
Total Non-Current Assets $58.77M $56.12M $58.92M $60.37M $60.37M
Net PPE $26.17M $44.82M $43.33M $44.77M $44.77M
-Gross PPE $36.54M $54.54M $52.50M $53.49M $53.49M
-Accumulated Depreciation -$10.37M -$9.73M -$9.17M -$8.72M -$8.72M
Other Non-Current Assets $32.60M $11.31M $15.59M $15.60M $15.60M
Total Liabilities $303.87M $291.86M $214.90M $214.83M $214.83M
Total Current Liabilities $90.55M $78.03M $51.25M $50.63M $50.63M
Payables $14.90M $12.15M $10.78M $8.08M $8.08M
-Accounts Payable $14.90M $12.15M $10.78M $8.08M $8.08M
Current Accrued Expenses $44.12M $46.36M $29.21M $37.55M $37.55M
Short-Term Debt and Capital Lease Obligation $5.56M $5.37M $5.03M $5.00M $5.00M
-Current Capital Lease Obligation $5.56M $5.37M $5.03M $5.00M $5.00M
Other Current Liabilities $25.97M $14.15M $6.22M – –
Total Non-Current Liabilities $213.32M $213.83M $163.65M $164.20M $164.20M
Long Term Debt and Capital Lease Obligation $213.32M $213.83M $163.65M $164.20M $164.20M
-Long Term Debt $200.01M $199.33M $149.38M $148.92M $148.92M
-Long Term Capital Lease Obligation $13.31M $14.51M $14.27M $15.28M $15.28M
Total Equity $930.93M $702.15M $865.06M $972.13M $972.13M
Stockholders' Equity $930.93M $702.15M $865.06M $972.13M $972.13M
Capital Stock $18,000.00 $16,000.00 $16,000.00 $16,000.00 $16,000.00
-Common Stock $18,000.00 $16,000.00 $16,000.00 $16,000.00 $16,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $2.82B $2.40B $2.38B $2.37B $2.37B
Retained Earnings -$1.89B -$1.70B -$1.52B -$1.40B -$1.40B
Gains/Losses Not Affecting Retained Earnings -$1.00M -$353,000.00 -$137,000.00 $475,000.00 $475,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$177.49M -$130.29M -$144.92M -$403.21M -$111.83M
Net cash flow from continuing operations -$177.49M -$130.29M -$144.92M -$403.21M -$111.83M
Net Income from Continuing Operations -$193.55M -$178.56M -$120.85M -$446.21M -$111.96M
Gain/Loss from Continuing Operations $36,000.00 – – $65,000.00 -$16,000.00
Depreciation & Depletion & Amortization $641,000.00 $560,000.00 $550,000.00 $2.05M $521,000.00
Other Non-Cash Items $344,000.00 $178,000.00 $195,000.00 $281,000.00 $91,000.00
Change in Working Capital -$936,000.00 $32.80M -$37.62M -$3.40M -$11.31M
-Change in Prepaid Assets -$2.38M $9.48M -$32.85M $986,000.00 -$2.20M
-Change in Payables and Accrued Expense $1.72M $18.96M -$4.80M $8.25M -$9.46M
-Change in Other Current Assets -$272,000.00 $4.35M $28,000.00 -$12.64M $350,000.00
Net cash flow from investing -$1.29M -$4.80M -$2.39M -$28.75M $982,000.00
Net Cash Flow from Continuing Investing Activities -$1.29M -$4.80M -$2.39M -$28.75M $982,000.00
Net PPE Purchase and Sale -$2.01M -$1.51M -$221,000.00 -$20.71M -$484,000.00
Net Investment Purchase and Sale $719,000.00 -$3.28M -$2.17M -$8.04M $1.47M
Financing Cash Flow $418.10M $58.11M $7.06M $890.31M $430.97M
Net Cash Flow from Continuing Financing Activities $418.10M $58.11M $7.06M $890.31M $430.97M
Net Issuance Payments Of Debt $11.23M $57.37M $6.21M $148.26M $49.45M
Net Common Stock Issuance $404.91M $0.00 $0.00 $734.61M $378.15M
Proceeds from Stock Option Exercised $2.03M $737,000.00 $1.31M $8.00M $3.37M
Net Other Financing Charges -$56,000.00 $0.00 -$454,000.00 -$558,000.00 -$9,000.00
Ending Cash Balance $917.84M – – $895.74M $895.74M
Net Change in Cash $239.32M – – $458.35M $320.12M
Beginning Cash Balance $678.52M – – $437.39M $575.63M
Free Cash Flow -$179.50M -$131.80M -$145.14M -$423.92M -$112.32M

Discussion

No comments yet — be the first to weigh in on DYN.

Sign in to join the discussion.

Scroll to Top